Promoter reporter studies for reported <i>NR5A1</i> mutations by Jana Malikova (615672)

Subjects:

Decreased IL-1β levels observed in HPV16 E6-positive cells are independent of autophagy or lysosomal degradation. by Martina Niebler (440620)

Inhibition of VEGF-A gene synthesis decreased ranibizumab and aflibercept mediated CCL2 CCL5, and CX3CL1 mRNA and protein levels in HCAECs. by Clare Arnott (2557705)

Stx16 depletion leads to decrease in E-cadherin levels and formation of multiple lumens in epithelial cysts. by Jae-Joon Jung (139625)

Methyl Gallate (MG) treatment decreases hepatocellular carcinoma (HCC) cell survival. by Chien-Yu Huang (802982)

Weight related parameters of subjects carrying (heterozygote) <i>NR5A1</i> mutations. by Jana Malikova (615672)

Subjects:

Rhox5 decreases UNC5C expression. by Mayumi Sugimoto (151133)

Silencing of RCC1L isoforms alter the levels of mitochondrial ribosomal proteins and biogenesis factors resulting in decreased mitochondrial translation. by Aurelio Reyes (412135)

IκBαM.1-Infected Mice Have Decreased Latency in Lung B Cells 16 dpi after Intranasal Infection by Laurie T Krug (68237)

Decreased growth of <i>S</i>. <i>aureus</i> CBS2016-05 and PS/BAC/317/16/W during PC storage in comparison to trypticase soy broth (TSB). by Basit Yousuf (630368)

Suppression does not depend on a growth rate decrease. by Laurent Jannière (28755)

<i>E</i> values weakly decrease with absolute latitude. by Dimitrios—Georgios Kontopoulos (9530566)

VRK1 overexpression is seen in human breast cancer and is associated with decreased relapse-free survival. by Aye M. Mon (5714912)

“…Data for cancer subtypes are shown in boxes numbered 1–11: 1: benign breast neoplasm (rank 6459, 1.4 fold-change, NS), 2: breast carcinoma (rank 833, 1.5 fold-change, p = 3.83x10^-5), 3: breast phyllodes tumor (rank 512, 1.2 fold-change, p = 0.002), 4: ductal breast carcinoma in situ (rank 1969, 1.5 fold-change, p = 0.002), 5: invasive breast carcinoma (rank 1060, 1.6 fold-change, p = 1.28x10^-5), 6: invasive ductal and invasive lobular breast carcinoma (rank 941, 1.5 fold-change, p = 6.76x10^-22), 7: invasive ductal breast carcinoma (rank 613, 1.5-fold change, p = 2.71x10^-71), 8: invasive lobular breast carcinoma (rank 947, 1.3 fold-change, p = 3.64x10^-28), 9: medullary breast carcinoma (rank 400, 1.8 fold-change, p = 3.25x10^-12), 10: mucinous breast carcinoma (rank 1932, 1.4 fold-change, p = 7.41x10^-10) and 11: tubular breast carcinoma (rank 1253, 1.4 fold-change, p = 1.24x10^-17). …”

Conditional depletion of RPS0A significantly decreases translation initiation rates. by Tomáš Kouba (153719)

Overexpression of Jagn1 decreases steady-state insulin levels. by Courtney Nosak (1807867)

cAMP and PKA/AKAP1 decrease mobility and promote mitochondrial translocation of Drp1. by Ronald A. Merrill (224222)

LAMP1 decreased within MoDCs infected with <i>P. gingivalis</i> expressing Mfa1. by Ahmed R. El-Awady (697683)

<i>Dmxl2</i> knockdown in INS-1E cells decreases glucose-induced insulin release. by Brooke Tata (633065)

“…Numerical data used to generate graphs 7B and 7C may be found in <a href="http://www.plosbiology.org/article/info:doi/10.1371/journal.pbio.1001952#pbio.1001952.s012" target="_blank">Table S5</a>.…”

Lung tumor development decreases the proportions of CD103⁺XCR1⁺ DC1s. by Julyanne Brassard (4117441)

Decreased TORC1 activates HPK-1 to extend longevity. by Ritika Das (4514968)